The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Bioresorbable scaffolds for the treatment of in-stent restenosis: an alternative to double metal layers?

EuroIntervention 2016;11:1451-1453. DOI: 10.4244/EIJV11I13A282

1. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. International Centre for Circulatory Health, Imperial College, London, United Kingdom

Drug-eluting stents (DES) have substantially decreased in-stent restenosis (ISR) rates compared to bare metal stents (BMS); however, ISR has not been eradicated completely. The halt of neointimal tissue growth with delayed endothelialisation by antiproliferative drugs creates uncovered struts which become well established sites for thrombus formation and ISR1. As a “fear” for the interventional cardiologists, ISR has been a hurdle that had to be overcome. Using a metallic DES implanted in a segment with a previous metallic cage implies its own risk of restenosis2. Adding a metallic layer induces inflammation within the vessel wall which can trigger a new ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Simulation training for the trainee cardiologist: the evidence mounts

Latest news